Nektar Therapeutics

Public Company, Headquarters Location
201 Industrial Rd., San Carlos, CA 94070-6211, United States
(650)631-3100, (650)631-3150 fax, http://www.nektar.com

Primary SIC: Pharmaceutical Preparations, Primary NAICS: Pharmaceutical Preparation Manufacturing
Description: Manufacturing: Services: Develops advanced drug delivery solutions for the biopharmaceutical industry. Manufacturing: Systems for pulmonary delivery of peptides, and proteins.

View this company profile - Now for a Limited Time, try Goliath Company Profiles
Free for 3 Days!

Nektar Therapeutics, News and Information

Nektar Therapeutics Promotes Lorianne Masuoka, M.D. to Senior Vice President and Chief Medical Officer.
Biotech Week; 12/16/2009; 563 words; Nektar Therapeutics (NASDAQ:NKTR) announced the...Officer, Howard W. Robin (see also Nektar Therapeutics). "Lorianne's outstanding...Conservation, Ecology, Environment, Nektar Therapeutics, Pharmaceutical Business, Pharmaceutical...

Winger Named To Nektar Therapeutics Board.
Investrend; 12/15/2009; 994 words; ...15/winger-named-to-nektar-therapeutics-board/) December 15, 2009 (FinancialWire) -- Nektar Therapeutics (NASDAQ: NKTR) has appointed...divisions of The Cooper Cos. Nektar Therapeutics is a biopharmaceutical company...

FORM 8-K: NEKTAR THERAPEUTICS ANNOUNCES DEPARTURE OF DIRECTORS OR CERTAIN OFFICERS, ELECTION OF DIRECTORS
US Fed News Service, Including US State News; 12/15/2009; 1275 words; WASHINGTON, Dec. 14 -- NEKTAR THERAPEUTICS, San Carlos, Calif., files...specified in its charter is NEKTAR THERAPEUTICS. State of Incorporation...the board of directors of Nektar Therapeutics, a Delaware corporation...

NEKTAR THERAPEUTICS REPORTS ACQUISITION BY SENIOR VP CHOWRIRA (California)
US Fed News Service, Including US State News; 11/30/2009; 297 words; WASHINGTON, Nov. 30 -- Nektar Therapeutics (NKTR), San Carlos, Calif., has filed a Form 4 with the Securities and Exchange Commission noting the change in the beneficial...

Reportlinker Adds Pulmonary Drug Delivery Technologies - A Global Market Perspective.
PR Newswire; 11/18/2009; 2277 words; ...Progress of ALN-RSV01 21 Bayer HealthCare and Nektar Therapeutics to Develop NKTR-061 21 AstraZeneca Launches SymbicortA...UK) 24 Graceway Pharmaceuticals, LLC (USA) 25 Nektar Therapeutics (USA) 25 Oriel Therapeutics, Inc. (USA) 25...

Why Purchase This Company Profile?

  • Sales prospecting
  • Competitive analysis
  • Vendor & supplier evaluation
  • Customer evaluation and analysis
  • Strategic planning

Need More Information?

Start a new search

Tell Us What You Think

Take our short survey to tell us what would make Goliath more valuable to you.

Add Your Company Information to Goliath
If your company does not appear in Goliath, click here to add it.

Update Your Company Information
If your company information has changed or is not correct,
click here to let us know.